Synthesis and biological evaluation of two analogues of (S)-α-methyl- 3-carboxyphenylalanine

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 18, 1998, Pages 2447-2450

  Ma, Dawei ^a   Ma, Zhaochun ^a   Kozikowski, Alan P ^b   Pshenichkin, Sergey ^b   Wroblewski, Jarda T ^b  

^a SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYL 3 PHOSPHONOPHENYLALANINE; DRUG ANALOG; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CHEMICAL BOND; CHEMICAL MODIFICATION; CHO CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; STEREOCHEMISTRY;

ANIMALS; CHO CELLS; CRICETINAE; MODELS, CHEMICAL; PHENYLALANINE; RECEPTORS, KAINIC ACID; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0032558530     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00409-0     Document Type: Article

References (27)

1. 1. For reviews, see a) Watkins, J.; Collingridge, G. Trends Pharmacol. Sci. 1994, 15, 333.
2. b) Knopfel, T.; Kuhn, R.; Allgeier, H., J. Med. Chem., 1995, 38, 1418.
3. c) Ornstein, P. L.; Schoepp, D. D.; Monn, J. A. Current Pharmaceutical Design, 1995, 1, 355.
4. d) Knopfel, T.; Gasparini, F. Drug Discovery today, 1996, 1, 103.
5. 2. Monn, J. A.; Valli, M. J.; Massey, S. M.; Wright, R. A.; Salhoff, C. R.; Johnson, B. R.; Howe, T.; Alt, C. A.; Rhodes, G. A.; Robey, R. L.; Griffey, K. R.; Tizzano, J. P.; Kallman, M. J.; Helton, D. R.; Schoepp. D. D. J. Med. Chem., 1997, 40, 528.
6. 3. Pellicciari, R.; Marinozzi, M.; Natalini, B.; Costantino, G.; Luneia, R.; Giorgi, G.; Moroni, F.; Thomsen, C. J. Med. Chem. 1996, 39, 2259. Pellicciari, R.; Luneia, R.; Costantino, G.; Marinozzi, M.; Natalini, B.; Jakobsen, P.; Kanstrup, A.; Lombardi, G.; Moroni, F.; Thomsen, C. J. Med. Chem. 1995, 38, 3717.
7. 3. Pellicciari, R.; Marinozzi, M.; Natalini, B.; Costantino, G.; Luneia, R.; Giorgi, G.; Moroni, F.; Thomsen, C. J. Med. Chem. 1996, 39, 2259. Pellicciari, R.; Luneia, R.; Costantino, G.; Marinozzi, M.; Natalini, B.; Jakobsen, P.; Kanstrup, A.; Lombardi, G.; Moroni, F.; Thomsen, C. J. Med. Chem. 1995, 38, 3717.
8. 4. Ma, D.; Tian, H.; Sun, H.; Kozikowski, A. P.; Pshenichkin, S.; Wroblewski, J. T. Bioorg. Med. Chem. Lett. 1997, 7, 1195.
9. 5. Sekiyama, N.; Hayashi, Y.; Nakanishi, S.; Jane, D. E.; Tse, H.-W.; Birse, E. F.; Watkins, J. C. Br. J. Pharmacol. 1996, 117, 1493, and references cited therein.
10. 6. Annoura, H.; Fukunaga, A.; Uesugi, M.; Tatsuoka, T.; Horikawa, Y. Bioorg. & Med. Chem. Lett. 1996, 6, 763.
11. 7. Wermuth, C. G.; Mann, A.; Schoenfelder, A.; Wright, R. A.; Johnson, B. G.; Bumett, J. P.; Mayne, N. G.; Schoepp, D. D. J. Med. Chem. 1996, 39, 814.
12. 50 for compound 1 is about 270 μM to antagonize the effect of 30 μM of L-AP4. See Schaffhauser, H.; Cartmell, J.; Jakob-Rotne, R.; Mutel, V. Neuropharmacology, 1997, 36, 933.
13. 50 for compound 1 is about 270 μM to antagonize the effect of 30 μM of L-AP4. See Schaffhauser, H.; Cartmell, J.; Jakob-Rotne, R.; Mutel, V. Neuropharmacology, 1997, 36, 933.
14. 9. Seebach, D.; Sting, A. R.; Hoffmann, M. Angew. Chem. Int. Ed. Engl. 1996, 35, 2708.
15. 10. Fadel, A.; Salaun, J. Tetrahedron Lett. 1987, 28, 2243.
16. 11. Ma, D.; Ma, Z.; Jiang, J.; Yang, Z.; Zheng, C. Tetrahedron: Asymmetry, 1997, 8, 889.
17. 12. Lu. X.; Zhu, J. Synthesis, 1987, 726.
18. 2O) δ 7.59 (dd, J= 12.0, 7.6 Hz, 1H), 7.48 (d, J = 12.0 Hz, 1H), 7.34 (ddd, J = 7.6, 7.6, 3.3 Hz, 1H), 7.22 (d, J = 7.6 Hz, 1H), 3.26 (d, J = 14.3 Hz, 1H), 2.96 (d, J = 14.3 Hz, 1H), 1.49 (s, 3H).
19. 14. Kato, H.; Koshinaka, E,; Nishikawa, T.; Arata, Y. J. Pharm. Soc. Jpn. 1974, 94, 934.
20. 15. Omstein, P. L.; Arnold, M. B.; Augenstein, N. K.; Paschal, J. W. J. Org. Chem. 1991, 56, 4388.
21. 16. Ma. D.; Tian, H. J. Chem. Soc. Perkin Trans 1, 1997, 3493.
22. 2O) δ 7.66 (d, J = 8.0 Hz, 1H), 7.64 (s, 1H), 7.22 (d, J = 8.0 Hz, 1H), 4.44 (d, J = 16.4 Hz, 1H), 4.31 (d, J = 16.4 Hz, 1H), 3.28 (d, J = 17.0 Hz, 1H), 3.04 (d, J = 17.0 Hz, 1H), 1.48 (s, 3H).
23. 18. Wroblewska, B.; Wroblewski, J. T.; Pshenichkin, S.; Surin, A.; Sullivan, S.; Neale, J. H. J. Neurochem. 1997, 69, 174.
24. 19. Tuckmantel, W.; Kozikowski, A. P.; Wang, S.; Pshenichkin, S.; Wroblemski, J. Bioorg. Med. Chem. Lett. 1997, 7, 601. Kozikowski, A. P.; Steensma, D.; Araldi, G. L.; Tuckmantel, W.; Wang, S.; Pshenichkin, S.; Surina, E.; Wroblewski, J. T. J. Med. Chem. 1998, 41, 1641.
25. 19. Tuckmantel, W.; Kozikowski, A. P.; Wang, S.; Pshenichkin, S.; Wroblemski, J. Bioorg. Med. Chem. Lett. 1997, 7, 601. Kozikowski, A. P.; Steensma, D.; Araldi, G. L.; Tuckmantel, W.; Wang, S.; Pshenichkin, S.; Surina, E.; Wroblewski, J. T. J. Med. Chem. 1998, 41, 1641.
26. 20. Wroblewski, B.; Wroblewski, J. T.; Saab, O. H.; Neale, J. H. J. Neurochem. 1993, 61, 943.
27. 21. Kemp, M. C.; Jane, D. E.; Tse, H-W.; Roberts, P. J. Br. J. Pharmacol. 1996, 117, 334p.